Applied Therapeutics (NASDAQ: APLT)
Applied Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Applied Therapeutics Company Info
Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company which engages in the development of a pipeline of novel products. It is targeting treatments for central nervous system rare diseases and diabetic complications. The company was founded by Shoshana Shendelman on January 20, 2016 and is headquartered in New York, NY.
News & Analysis
Why Applied Therapeutics Stock Is Sliding Today
The company's lead candidate, AT-007, is going to take a lot longer to reach patients than expected.
3 Top Biotech Stocks to Buy in February
These three clinical-stage biotechs could all double in value before year's end.
Here's Why Applied Therapeutics Rocketed Higher Today
Stellar results from a phase 2 study have investors excited about the biotech's prospects.
These Were the 10 Best IPOs of 2019
Incredibly, they're almost all health stocks, including 7 biotechs, an eye surgery platform, and a medical device company.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.